Apria, Inc. INDIANAPOLIS, Feb. (the “Company” or “Apria”) (Nasdaq: APR) announced today the pricing of its initial public offering of 7,500,000 shares of its common stock at a price to the public of $20.00 per share. …

Is Apria stock a buy?

Apria has received a consensus rating of Buy. The company’s average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.

Should I buy signify health Stock?

Signify Health has received a consensus rating of Buy. The company’s average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

Is signify health profitable?

Signify Health Fast Facts Signify Health’s annual revenues are over $500 million (see exact revenue data) and has over 1,000 employees. It is classified as operating in the Physicians, Mental Health Specialists industry.

Show less

Apria (APR) is in the news Thursday after announcing the launch of the healthcare company’s IPO and we have all the details. The post Apria IPO: 14 Things for Potential APR Stock Investors to Know About…

What are the analysts price targets for Apria?

Their forecasts range from $26.00 to $33.00. On average, they anticipate Apria’s share price to reach $29.83 in the next twelve months. This suggests a possible upside of 6.6% from the stock’s current price. View analysts’ price targets for Apria or view top-rated stocks among Wall Street analysts.

What kind of services does Apria Healthcare Group offer?

Apria Healthcare Group Inc. is engaged in offering a range of clinical services and equipment. The Company offers therapies, clinical programs and services.

When is Apria’s first quarter of 2021 release date?

INDIANAPOLIS, May 13, 2021 (GLOBE NEWSWIRE) — Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of integrated home healthcare equipment and related services in the U.S., announced today financial results for the first quarter ended March 31, 2021.